NJ Med School Gets Army Contract to Define Molecular Signatures of Biological Warfare Agents | GenomeWeb

As concerns mount about preparedness for bioterrorism in the US, one microarray lab has already begun applying biochip technology to develop gene-based detection platforms for exposure to biological warfare agents.

The Center for Applied Genomics at the Public Health Research Institute in Newark, NJ, working jointly with the New Jersey Medical School Center for Emerging and Reemerging Pathogens, has obtained a contract with the US Army, funding a project beginning in October to develop microarray-based molecular diagnostics for biological agents.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.